Original news and analysis on international IP policy
Ukrainian lawmakers are poised to approve sweeping patent reform legislation, driven in large part by a push by patients’ groups for better access to affordable medicines and healthcare.
Historicamente, o Brasil se encontra na vanguarda dos países em desenvolvimento, pressionando por um regime de propriedade intelectual (PI) mais equilibrado.
The Brazilian government's plan to deal with its patent backlog by making approvals without review is a recipe for disaster. It will move the backlog to the courts, with endless suits over duplicative and frivolous patents, write Arjun Jayadev and Dean Baker.
Developed country attachés in Geneva for intellectual property and for health are invited to meet in a closed session tomorrow to exchange information in the run-up to the annual World Health Assembly taking place in late May.
The annual Special 301 report of the Office of the United States Trade Representative (USTR) issued today sparked a quick outcry among health advocates over its seemingly more restrictive approach they say bullies other countries into unfairly promoting US pharmaceutical industry rights to an extent that would raise drug prices and limit accessibility.
The annual report of the Office of the United States Trade Representative (USTR) on the adequacy of trading partners’ protection of US intellectual property rights celebrated its 30th year this year with a sharper tone with China, in keeping with the Trump administration’s tough stance on the country. Also caught in the report are Colombia and Canada, which were downgraded to the “priority watch list.” Also, this year the report includes a special highlight on pharmaceuticals and medical devices.
The European Commission today issued an outline of a European approach on artificial intelligence to "boost investment and set ethical guidelines." The aim is to have a coordinated plan with member states by year's end.
Weevil-infested flour, deadly methanol added to alcohol, borax to make products seem fresher, pesticide-laced shrimp, fake medicines. Global police organisation Interpol today detailed a multi-agency operation that dismantled nearly 50 criminal networks worldwide that provided fake and substandard food and drink that put people in danger and killed dozens.
The Medicines Patent Pool announced today that it has appointed Charles Gore as new executive director. Gore is founder and former president of the World Hepatitis Alliance.
Prof. Carlos Correa of Argentina, an influential academic whose analyses of patents and medicines access have informed debates and challenged the status quo for decades, has been named the next executive director of the South Centre. He will take over for Martin Khor, who will be retiring after nine years at the helm. Separately, former South African President Thabo Mbeki was named chair of the Board.